Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Tax Rate (2021 - 2025)

Kiniksa Pharmaceuticals International (KNSA) has disclosed Tax Rate for 5 consecutive years, with 19.19% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Tax Rate fell 11473.0% year-over-year to 19.19%, compared with a TTM value of 19.58% through Dec 2025, up 1657.0%, and an annual FY2025 reading of 19.58%, up 1657.0% over the prior year.
  • Tax Rate was 19.19% for Q4 2025 at Kiniksa Pharmaceuticals International, down from 32.12% in the prior quarter.
  • Across five years, Tax Rate topped out at 1308.39% in Q2 2023 and bottomed at 379.5% in Q3 2022.
  • Average Tax Rate over 5 years is 60.56%, with a median of 0.53% recorded in 2021.
  • The sharpest move saw Tax Rate surged 131211bps in 2023, then tumbled -103878bps in 2024.
  • Year by year, Tax Rate stood at 0.64% in 2021, then skyrocketed by 5562bps to 34.79% in 2022, then crashed by -66bps to 11.76% in 2023, then skyrocketed by 713bps to 95.55% in 2024, then crashed by -120bps to 19.19% in 2025.
  • Business Quant data shows Tax Rate for KNSA at 19.19% in Q4 2025, 32.12% in Q3 2025, and 22.05% in Q2 2025.